Javaglim MV 2mg/500mg/0.2mg Tablet
Marketer
Manojava Lifescience Private Limited
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Javaglim MV 2mg/500mg/0.2mg Tablet
Diabeva Trio 2mg/500mg/0.2mg tablets are classified as antidiabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes mellitus to effectively manage blood glucose levels. Diabeva Trio should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined individually by your physician and may be adjusted based on your glycemic response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. Remember, this medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most frequent adverse effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to treat them. Consistent mealtimes and carrying a fast-acting glucose source (e.g., sugary foods, fruit juice) are crucial preventative measures. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician prior to commencing treatment. Pregnant or lactating women should consult their doctor before use. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.
Uses of Javaglim MV 2mg/500mg/0.2mg Tablet
Managing type 2 diabetes
Major Benefits of Javaglim MV 2mg/500mg/0.2mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Javaglim MV 2mg/500mg/0.2mg Tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
Common Side effects of Javaglim MV 2mg/500mg/0.2mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Javaglim MV 2mg/500mg/0.2mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Take Javaglim MV 2mg/500mg/0.2mg tablets on an empty stomach.
How Javaglim MV 2mg/500mg/0.2mg Tablet works:
Each Javaglim MV 2mg/500mg/0.2mg tablet contains a triple-action antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Javaglim MV 2mg/500mg/0.2mg tablets with alcohol is not recommended due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Javaglim MV 2mg/500mg/0.2mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Patient consultation with their doctor is advised.
Breast feedingCONSULT YOUR DOCTOR
The use of Javaglim MV 2mg/500mg/0.2mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyUNSAFE
Patients with kidney disease should likely avoid Javaglim MV 2mg/500mg/0.2mg Tablets, as their use may be unsafe. Medical advice should be sought before taking this medication. The use of Javaglim MV 2mg/500mg/0.2mg Tablets is particularly discouraged for those with severe kidney impairment.
LiverCAUTION
Patients with liver impairment should use Javaglim MV 2mg/500mg/0.2mg tablets cautiously, potentially requiring dose modification. A physician's consultation is recommended. In those with mild to moderate liver disease, initiation should be at a low dosage; however, it's contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Javaglim MV 2mg/500mg/0.2mg Tablet :
Should you forget to take a Javaglim MV 2mg/500mg/0.2mg Tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Javaglim MV 2mg/500mg/0.2mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Treatment |
3,018 People bought this recently